HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xu, H. Articles by Chong, A. S.-F. Search for Related Content PubMed PubMed Citation Articles by Xu, H. Articles by Chong, A. S.-F.

The In Vitro and In Vivo Effects of Anti-Galactose Antibodies on Endothelial Cell Activation and Xenograft Rejection ¹

Hui Xu^2,*, Dengping Yin, Bashoo Naziruddin^*, Libing Chen^*, Aileen Stark^*, Yuanyuan Wei^*, Ying Lei^*, JiKun Shen, John S. Logan^*, Guerard W. Byrne^* and Anita S.-F. Chong^3,

^* Nextran, Princeton, NJ 08540; and Department of General Surgery, Rush Presbyterian St. Luke’s Medical Center, Chicago, IL 60612

We have previously produced a series of antigalactose (anti-Gal) hybridomas and characterized their heavy chain gene usage. Here we have quantified the affinity of these Abs for the -Gal epitope and characterized their in vitro effects on endothelial cell activation and apoptosis. We report that anti-Gal mAbs derived from Gal^-/- mice show a range of affinity for the -Gal epitope, and that affinity was generally increased as the V_H gene usage transitioned from germline sequences to sequences exhibiting somatic maturation. Despite an 85-fold range in affinity, all the anti-Gal mAbs examined induced -Gal-specific endothelial cell activation, and after prolonged exposure induced endothelial cell apoptosis in a complement-independent manner. Only murine anti-Gal mAbs of the IgM or IgG3 subclass, but not IgG1, were effective at initiating complement-dependent cell lysis. Using a novel rat to mouse xenograft model, we examined the in vivo ability of these mAbs to induce xenograft rejection and characterized the rejection using histology and immunohistochemistry. Infusion of complement-fixing IgG3 mAbs resulted in either hyperacute rejection or acute vascular rejection of the xenograft. Surprisingly, infusion of an equal amount of a high affinity anti-Gal IgG1 mAb, that fixed complement poorly also induced a rapid xenograft rejection, which we have labeled very acute rejection. These studies emphasize the importance of in vivo assays, in addition to in vitro assays, in understanding the role of anti-Gal IgG-mediated tissue injury and xenograft rejection.

This article has been cited by other articles:

				J. W. Ding, T. Zhou, H. Zeng, L. Ma, J. S. Verbeek, D. Yin, J. Shen, and A. S. Chong Hyperacute Rejection by Anti-Gal IgG1, IgG2a, and IgG2b Is Dependent on Complement and Fc-{gamma} Receptors J. Immunol., January 1, 2008; 180(1): 261 - 268. [Abstract] [Full Text] [PDF]

				J. Milland, D. Christiansen, B. D. Lazarus, S. G. Taylor, P. X. Xing, and M. S. Sandrin The Molecular Basis for Gal{alpha}(1,3)Gal Expression in Animals with a Deletion of the {alpha}1,3Galactosyltransferase Gene J. Immunol., February 15, 2006; 176(4): 2448 - 2454. [Abstract] [Full Text] [PDF]

				D. Yin, H. Zeng, L. Ma, J. Shen, H. Xu, G. W. Byrne, and A. S. Chong Cutting Edge: NK Cells Mediate IgG1-Dependent Hyperacute Rejection of Xenografts J. Immunol., June 15, 2004; 172(12): 7235 - 7238. [Abstract] [Full Text] [PDF]